Digital Therapeutic (DTx) Market Worth USD 6.9 Billion (At A CAGR Of 5.4%)
B2B segment is expected to grow at the highest CAGR during the forecast period
Based on the sales channel, the digital therapeutics market is segmented into business-to-customer (B2C) and business-to-business (B2B). In 2019, the B2B segment accounted for the largest market share; it is also expected to grow at the highest CAGR of the digital therapeutics market. There is growing awareness among...
Digital Therapeutic (DTx) Market To reach USD 6.9 billion by 2025Technological Advancements In Mobile Healthcare
The study involved four major activities in estimating the current size of the global digital therapeutics market. Exhaustive secondary research was conducted to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing values with industry experts across the value chain through primary research.
What the Market...
Global Digital Therapeutic (DTx) Market | Global Industry Growth, Demand, Trends, Insights and Forecast 2025
The growth of the digital therapeutics market is primarily driven by factors such as government initiatives for preventive healthcare, technological advancements in mobile healthcare, a significant increase in venture capital investments, and the benefits of digital therapeutics, such as the ability to induce behavioral change (an important challenge in healthcare), user-friendliness, patient convenience,...
New release: Digital Therapeutic (DTx) Market worth USD 6.9 billion by 2025
According to the new market research report ” Digital Therapeutic (DTx) Market by Application (Prediabetes, Nutrition, Care, Diabetes, CVD, CNS, CRD, MSD, GI, Substance Abuse, Rehabilitation), Sales Channel (B2C, Patient, Caregiver, B2B, Providers, Payer, Employer, Pharma) – Global forecasts to 2025″, , published by MarketsandMarkets™, The global digital therapeutics...